Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis, August 2013
The global pharmaceutical industry revenue is forecasted to reach an estimated $1,226.0 billion by 2018, with good growth over the next five years (2013-2018). The industry is expected to register growth led by aging population, changing lifestyles, hectic daily activities, unhealthy eating habits, increasing incidence of chronic diseases across the entire global population providing growth opportunities for the industry players.
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in “Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The industry is engaged in discovery, development, manufacture, and marketing of prescription drugs. Industry products include ethical drugs and consumer healthcare but animal healthcare drugs are not included. The global pharmaceutical market faces major challenge from increasing investment and strict regulation. Changing lifestyles and the fast socio-demographic shift due to urbanization in both developed and growth markets globally are expected drive the demand. The ability to create new technology and innovative drugs is a key driver for success in this market.
North America is projected to lead the pharmaceutical industry. Vaccine industry is expected to record the highest growth during the forecast period. ROW industry is expected to witness the highest growth during 2013-2018. Government initiatives in Brazil to encourage drugs industries by providing free pricing policies and special financial investment options will attract the industry players. APAC holds good growth potential for the future.
This study provides an overview of the global pharmaceutical industry by tracking 13 market segments of that industry in four geographic regions. Thus, a total of 52 segments of the global pharmaceutical industry are tracked. The report studies manufacturers of bone, respiratory, immunology and dermatology, cardiovascular, diabetes & obesity, urinary/kidney diseases, gastrointestinal, neurosciences, infectious diseases, ophthalmology, oncology, women’s health/ endocrine, vaccines, consumer health/OTC, and others providing a five-year (2007-2012) annual trend analysis that highlights market size, profit and cost structure for NA, Europe, APAC, and ROW. The report also provides a forecast, addressing market opportunities for next five years (2013-2018) for each of these regions.
This comprehensive guide from Lucintel provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save Lucintel clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global pharmaceutical industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis.
Features and Scope of this Report:
To make any investment or strategic decision, you need adequate and timely information. This market report fulfills this core need. Some of the features of this market report are:
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in “Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The industry is engaged in discovery, development, manufacture, and marketing of prescription drugs. Industry products include ethical drugs and consumer healthcare but animal healthcare drugs are not included. The global pharmaceutical market faces major challenge from increasing investment and strict regulation. Changing lifestyles and the fast socio-demographic shift due to urbanization in both developed and growth markets globally are expected drive the demand. The ability to create new technology and innovative drugs is a key driver for success in this market.
North America is projected to lead the pharmaceutical industry. Vaccine industry is expected to record the highest growth during the forecast period. ROW industry is expected to witness the highest growth during 2013-2018. Government initiatives in Brazil to encourage drugs industries by providing free pricing policies and special financial investment options will attract the industry players. APAC holds good growth potential for the future.
This study provides an overview of the global pharmaceutical industry by tracking 13 market segments of that industry in four geographic regions. Thus, a total of 52 segments of the global pharmaceutical industry are tracked. The report studies manufacturers of bone, respiratory, immunology and dermatology, cardiovascular, diabetes & obesity, urinary/kidney diseases, gastrointestinal, neurosciences, infectious diseases, ophthalmology, oncology, women’s health/ endocrine, vaccines, consumer health/OTC, and others providing a five-year (2007-2012) annual trend analysis that highlights market size, profit and cost structure for NA, Europe, APAC, and ROW. The report also provides a forecast, addressing market opportunities for next five years (2013-2018) for each of these regions.
This comprehensive guide from Lucintel provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save Lucintel clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global pharmaceutical industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis.
Features and Scope of this Report:
To make any investment or strategic decision, you need adequate and timely information. This market report fulfills this core need. Some of the features of this market report are:
- Industry size estimates in terms of (US $) value by regions and by segments
- Global pharmaceutical industry annual trend (2007-2012) and forecast (2013-2018)
- Porter’s Five Force analysis
- New product launch, merger and acquisition activity in global pharmaceutical industry
- Gross and net profit trends in the global pharmaceutical industry
- Cost structure trend in the global as well as regional pharmaceutical industry
1. EXECUTIVE SUMMARY
2. GLOBAL PHARMACEUTICAL INDUSTRY BACKGROUND AND CLASSIFICATION
2.1: An introduction to global pharmaceutical industry
2.1.1: Lucintel pharmaceutical industry and segmentation
2.1.2: Key applications of global pharmaceutical industry
2.1.3: Supply chain for global pharmaceutical industry
2.2: Global pharmaceutical industry analysis based on Porter’s Five Forces Model
3. MARKET ANALYSIS
3.1: Global pharmaceutical industry current market analysis 2012
3.1.1: Global pharmaceutical industry by value 2012
3.1.2: Regional pharmaceutical industry by value 2012
3.2: Market trend 2007–2012
3.2.1: Macroeconomic trends
3.2.2: Global pharmaceutical industry market trends 2007-2012
3.2.3: North America 2012 industry trend by value
3.2.4: Europe 2012 industry trend
3.2.5: APAC 2012 industry trend
3.2.6: ROW 2012 industry trend
3.2.7: Segment pharmaceutical industry market trends 2007-2012 by value
3.3: Industry drivers and challenges
3.4: Market forecast for global pharmaceutical industry 2013-2018
3.4.1: Macroeconomic forecast 2013-2018
3.4.2: Global market forecast
3.4.3: North American pharmaceutical market forecast by value
3.4.4: Europe market forecast by value
3.4.5: APAC market forecast by value
3.4.6: ROW market forecast by value
3.4.7: Global pharmaceutical industry segment forecast by value
4. Financial (Cost Structure, Profitability, Debt, and Asset) Analysis
4.1: Profitability assessment for global pharmaceutical industry
4.1.1: Global cost trends
4.1.2: Regional cost trends
4.2: Assets analysis
4.3: Debt analysis
5. COMPETITIVE LANDSCAPE AND GROWTH OPPORTUNITIES ANALYSIS
5.1: Product portfolio analysis
5.2: Market share analysis
5.3: Growth leadership analysis
5.4: Growth opportunity analysis
6. INDUSTRY STRATEGIC ASSESSMENT
6.1: Emerging trends in global pharmaceutical industry
6.2: Unmet needs in global pharmaceutical industry
6.3: Innovation and new products launches in global pharmaceutical industry
6.4: Mergers and acquisitions in global pharmaceutical industry
7. COMPANY PROFILES FOR LEADING PLAYERS
2. GLOBAL PHARMACEUTICAL INDUSTRY BACKGROUND AND CLASSIFICATION
2.1: An introduction to global pharmaceutical industry
2.1.1: Lucintel pharmaceutical industry and segmentation
2.1.2: Key applications of global pharmaceutical industry
2.1.3: Supply chain for global pharmaceutical industry
2.2: Global pharmaceutical industry analysis based on Porter’s Five Forces Model
3. MARKET ANALYSIS
3.1: Global pharmaceutical industry current market analysis 2012
3.1.1: Global pharmaceutical industry by value 2012
3.1.2: Regional pharmaceutical industry by value 2012
3.2: Market trend 2007–2012
3.2.1: Macroeconomic trends
3.2.2: Global pharmaceutical industry market trends 2007-2012
3.2.3: North America 2012 industry trend by value
3.2.4: Europe 2012 industry trend
3.2.5: APAC 2012 industry trend
3.2.6: ROW 2012 industry trend
3.2.7: Segment pharmaceutical industry market trends 2007-2012 by value
3.3: Industry drivers and challenges
3.4: Market forecast for global pharmaceutical industry 2013-2018
3.4.1: Macroeconomic forecast 2013-2018
3.4.2: Global market forecast
3.4.3: North American pharmaceutical market forecast by value
3.4.4: Europe market forecast by value
3.4.5: APAC market forecast by value
3.4.6: ROW market forecast by value
3.4.7: Global pharmaceutical industry segment forecast by value
4. Financial (Cost Structure, Profitability, Debt, and Asset) Analysis
4.1: Profitability assessment for global pharmaceutical industry
4.1.1: Global cost trends
4.1.2: Regional cost trends
4.2: Assets analysis
4.3: Debt analysis
5. COMPETITIVE LANDSCAPE AND GROWTH OPPORTUNITIES ANALYSIS
5.1: Product portfolio analysis
5.2: Market share analysis
5.3: Growth leadership analysis
5.4: Growth opportunity analysis
6. INDUSTRY STRATEGIC ASSESSMENT
6.1: Emerging trends in global pharmaceutical industry
6.2: Unmet needs in global pharmaceutical industry
6.3: Innovation and new products launches in global pharmaceutical industry
6.4: Mergers and acquisitions in global pharmaceutical industry
7. COMPANY PROFILES FOR LEADING PLAYERS
LIST OF FIGURES
CHAPTER 2. GLOBAL PHARMACEUTICAL INDUSTRY BACKGROUND AND CLASSIFICATION
Figure 2.1: Key applications of global pharmaceutical industry
Figure 2.2: Supply chain-global pharmaceutical industry
Figure 2.3: Porter’s Five Forces model for global pharmaceutical industry
Figure 2.4: Industry life cycle
Figure 2.5: Global pharmaceutical industry net profit trends 2007-20012
CHAPTER 3. MARKET ANALYSIS
Figure 3.1: Global pharmaceutical industry market size ($B)
Figure 3.2: Global GDP growth rate trend
Figure 3.3: Global population growth rate trend
Figure 3.4: Global inflation rate trend
Figure 3.5: Global unemployment rate trend
Figure 3.6: Regional GDP growth rate trends at constant price
Figure 3.7: Regional population growth rate trend
Figure 3.8: Population age structure 2012
Figure 3.9: Regional inflation rate trend
Figure 3.10: Regional unemployment rate trend
Figure 3.11: Global and regional per capita income trend
Figure 3.12: Global pharmaceutical market trends by region 2007-2012 ($B)
Figure 3.13: Global pharmaceutical industry market trends by region 2007-2012 (%)
Figure 3.14: North America pharmaceutical industry market trends 2007-12
Figure 3.15: European pharmaceutical industry market trends 2007-2012
Figure 3.16: APAC pharmaceutical industry market Trends 2007-2012
Figure 3.17: ROW pharmaceutical industry trends 2007-2012
Figure 3.18: Global pharmaceutical industry trends by segment 2007-12 ($B)
Figure 3.19: Global pharmaceutical industry trends by segment 2007-2012 (%)
Figure 3.20: Key drivers and challenges for global pharmaceutical industry
Figure 3.21: Global GDP growth rate forecast
Figure 3.22: Global population growth rate forecast
Figure 3.23: Global inflation rate forecast
Figure 3.24: Global unemployment rate forecast
Figure 3.25: Regional GDP growth rate forecast at constant price
Figure 3.26: Regional population growth rate forecast
Figure 3.27: Population age structure 2018
Figure 3.28: Regional inflation rate forecast
Figure 3.29: Regional unemployment rate forecast
Figure 3.30: Global and regional per capita income forecast
Figure 3.31: Global pharmaceutical industry annual forecast 2013-2018 ($B)
Figure 3.32: Global pharmaceutical industry regional forecast 2013-2018 ($B)
Figure 3.33: North America pharmaceutical industry forecast
Figure 3.34: European pharmaceutical industry forecast
Figure 3.35: APAC pharmaceutical industry forecast
Figure 3.36: ROW pharmaceutical industry forecast
Figure 3.37: Global pharmaceutical industry segment forecast 2013-2018 ($B)
Figure 3.38: Global pharmaceutical industry segment forecast 2013-2018 (%)
CHAPTER 4. FINANCIAL (COST STRUCTURE, PROFITABILITY, DEBT, AND ASSET) ANALYSIS
Figure 4.1: Global pharmaceutical industry profitability trend 2007-2012
Figure 4.2: Cost structure of global pharmaceutical industry 2007-12012 (%)
Figure 4.3: Cost structure in North America pharmaceutical industry 2007-2012 (%)
Figure 4.4: Cost structure in European pharmaceutical industry 2007-2012 (%)
Figure 4.5: Cost structure in Asia Pacific pharmaceutical industry 2007-2012 (%)
Figure 4.6: Asset for global pharmaceutical industry 2007-2012 (%)
Figure 4.7: Debt for global pharmaceutical industry 2007-12 (%)
CHAPTER 5. COMPETITIVE LANDSCAPE AND GROWTH OPPORTUNITIES ANALYSIS
Figure 5.1: Presence of major players by segment
Figure 5.2: Global market share of pharmaceutical manufacturers 2012
Figure 5.3: Market share of top players in global pharmaceutical industry
Figure 5.4: Growth leadership matrix in global pharmaceutical industry
Figure 5.5: Global pharmaceutical industry opportunity by segment
Figure 5.6: Global pharmaceutical industry by region
CHAPTER 6. INDUSTRY STRATEGIC ASSESSMENT
Figure 6.1: Emerging trends in global pharmaceutical industry
Figure 6.2: Unmet needs in global pharmaceutical industry
CHAPTER 2. GLOBAL PHARMACEUTICAL INDUSTRY BACKGROUND AND CLASSIFICATION
Figure 2.1: Key applications of global pharmaceutical industry
Figure 2.2: Supply chain-global pharmaceutical industry
Figure 2.3: Porter’s Five Forces model for global pharmaceutical industry
Figure 2.4: Industry life cycle
Figure 2.5: Global pharmaceutical industry net profit trends 2007-20012
CHAPTER 3. MARKET ANALYSIS
Figure 3.1: Global pharmaceutical industry market size ($B)
Figure 3.2: Global GDP growth rate trend
Figure 3.3: Global population growth rate trend
Figure 3.4: Global inflation rate trend
Figure 3.5: Global unemployment rate trend
Figure 3.6: Regional GDP growth rate trends at constant price
Figure 3.7: Regional population growth rate trend
Figure 3.8: Population age structure 2012
Figure 3.9: Regional inflation rate trend
Figure 3.10: Regional unemployment rate trend
Figure 3.11: Global and regional per capita income trend
Figure 3.12: Global pharmaceutical market trends by region 2007-2012 ($B)
Figure 3.13: Global pharmaceutical industry market trends by region 2007-2012 (%)
Figure 3.14: North America pharmaceutical industry market trends 2007-12
Figure 3.15: European pharmaceutical industry market trends 2007-2012
Figure 3.16: APAC pharmaceutical industry market Trends 2007-2012
Figure 3.17: ROW pharmaceutical industry trends 2007-2012
Figure 3.18: Global pharmaceutical industry trends by segment 2007-12 ($B)
Figure 3.19: Global pharmaceutical industry trends by segment 2007-2012 (%)
Figure 3.20: Key drivers and challenges for global pharmaceutical industry
Figure 3.21: Global GDP growth rate forecast
Figure 3.22: Global population growth rate forecast
Figure 3.23: Global inflation rate forecast
Figure 3.24: Global unemployment rate forecast
Figure 3.25: Regional GDP growth rate forecast at constant price
Figure 3.26: Regional population growth rate forecast
Figure 3.27: Population age structure 2018
Figure 3.28: Regional inflation rate forecast
Figure 3.29: Regional unemployment rate forecast
Figure 3.30: Global and regional per capita income forecast
Figure 3.31: Global pharmaceutical industry annual forecast 2013-2018 ($B)
Figure 3.32: Global pharmaceutical industry regional forecast 2013-2018 ($B)
Figure 3.33: North America pharmaceutical industry forecast
Figure 3.34: European pharmaceutical industry forecast
Figure 3.35: APAC pharmaceutical industry forecast
Figure 3.36: ROW pharmaceutical industry forecast
Figure 3.37: Global pharmaceutical industry segment forecast 2013-2018 ($B)
Figure 3.38: Global pharmaceutical industry segment forecast 2013-2018 (%)
CHAPTER 4. FINANCIAL (COST STRUCTURE, PROFITABILITY, DEBT, AND ASSET) ANALYSIS
Figure 4.1: Global pharmaceutical industry profitability trend 2007-2012
Figure 4.2: Cost structure of global pharmaceutical industry 2007-12012 (%)
Figure 4.3: Cost structure in North America pharmaceutical industry 2007-2012 (%)
Figure 4.4: Cost structure in European pharmaceutical industry 2007-2012 (%)
Figure 4.5: Cost structure in Asia Pacific pharmaceutical industry 2007-2012 (%)
Figure 4.6: Asset for global pharmaceutical industry 2007-2012 (%)
Figure 4.7: Debt for global pharmaceutical industry 2007-12 (%)
CHAPTER 5. COMPETITIVE LANDSCAPE AND GROWTH OPPORTUNITIES ANALYSIS
Figure 5.1: Presence of major players by segment
Figure 5.2: Global market share of pharmaceutical manufacturers 2012
Figure 5.3: Market share of top players in global pharmaceutical industry
Figure 5.4: Growth leadership matrix in global pharmaceutical industry
Figure 5.5: Global pharmaceutical industry opportunity by segment
Figure 5.6: Global pharmaceutical industry by region
CHAPTER 6. INDUSTRY STRATEGIC ASSESSMENT
Figure 6.1: Emerging trends in global pharmaceutical industry
Figure 6.2: Unmet needs in global pharmaceutical industry
LIST OF TABLES
CHAPTER 1. EXECUTIVE SUMMARY
Table 1.1: Global pharmaceutical industry market parameters & attributes
CHAPTER 4. FINANCIAL (COST STRUCTURE, PROFITABILITY, DEBT, AND ASSET) ANALYSIS
Table 4.1: Percentage change in asset
Table 4.2: Percentage change in debt
CHAPTER 5. COMPETITIVE LANDSCAPE AND GROWTH OPPORTUNITIES ANALYSIS
Table 5.1: Market share of top three players
Table 5.2: Ranking of leaders in major market segments
CHAPTER 1. EXECUTIVE SUMMARY
Table 1.1: Global pharmaceutical industry market parameters & attributes
CHAPTER 4. FINANCIAL (COST STRUCTURE, PROFITABILITY, DEBT, AND ASSET) ANALYSIS
Table 4.1: Percentage change in asset
Table 4.2: Percentage change in debt
CHAPTER 5. COMPETITIVE LANDSCAPE AND GROWTH OPPORTUNITIES ANALYSIS
Table 5.1: Market share of top three players
Table 5.2: Ranking of leaders in major market segments
